no statement of use filed
on 05 Jun 2023
Last Applicant/ Owned by
86 Morris Avenue
Summit
NJ
07901
Serial Number
90860805 filed on 02th Aug 2021
Registration Number
N/A
Correspondent Address
Xiomara Triana
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprolRead More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical and biological preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders, and monoclonal antibodies for medical use
No 90860805
No Service/Collective Mark
No 00160175-US
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
05th Jun 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
05th Jun 2023 | ABANDONMENT - NO USE STATEMENT FILED |
01st Nov 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
06th Sep 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
06th Sep 2022 | PUBLISHED FOR OPPOSITION |
17th Aug 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
30th Jul 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
29th Jul 2022 | EXAMINER'S AMENDMENT ENTERED |
29th Jul 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
29th Jul 2022 | EXAMINERS AMENDMENT -WRITTEN |